Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Injection Cu(DDC)2 protein nano-particle preparation used for treating tumor, and preparation method thereof

A nanoparticle and injection technology, applied in the field of pharmaceutical preparations, can solve the problems of poor water solubility, less toxic and side effects, and achieve the effects of less discomfort, high safety, and less hospitalization time.

Inactive Publication Date: 2013-07-31
SHENYANG PHARMA UNIVERSITY
View PDF1 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The object of the present invention is to provide Cu (DDC) for injection for treating tumors 2 Nanoparticle preparation and preparation method thereof, the preparation solves Cu(DDC) 2 The problem of poor water solubility, nano-scale Cu(DDC) for intravenous injection with protein as drug carrier 2 Preparation, has the advantages of high efficacy, less toxic and side effects, long-lasting effect, good stability, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Injection Cu(DDC)2 protein nano-particle preparation used for treating tumor, and preparation method thereof
  • Injection Cu(DDC)2 protein nano-particle preparation used for treating tumor, and preparation method thereof
  • Injection Cu(DDC)2 protein nano-particle preparation used for treating tumor, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046]3mg Cu(DDC) 2 Dissolve in 3mL of dichloromethane, add to 36.0mL human serum albumin double distilled water solution (1%w / v) under stirring, stir in ice bath for 10min, ultrasonicate for 9min under the condition of ultrasonic power 300W (3s / 1s), 25℃ Dichloromethane was removed by rotary evaporation under reduced pressure to obtain Cu(DDC) 2 Albumin nanoparticles, the particle size range is 120nm-160nm. The obtained Cu(DDC) 2 Nanoparticle TEM see figure 1 .

Embodiment 2

[0048] 3mg Cu(DDC) 2 Dissolve in 3 mL of chloroform, add to 30.0 mL of human serum albumin double-distilled aqueous solution (1% w / v) under stirring, stir in ice bath for 10 min, ultrasonicate for 9 min under the condition of ultrasonic power 300W (3s / 1s), 50℃ Remove chloroform by rotary evaporation under reduced pressure to obtain Cu(DDC) 2 Albumin nanoparticles, the particle size range is 120nm-160nm. Trehalose was added as a lyoprotectant.

Embodiment 3

[0050] 3mg Cu(DDC) 2 Dissolve in 3mL acetone, add to 24.0mL human serum albumin double distilled water solution (1%w / v) under stirring, stir in ice bath for 10min, ultrasonicate for 9min under the condition of ultrasonic power 300W (3s / 1s), decompress at 45℃ Acetone was removed by rotary evaporation to obtain Cu(DDC) 2 Albumin nanoparticles, the particle size range is 120nm-160nm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A compound Cu(DDC)2 with relatively high tumor-inhibiting activity can be used for treating cancers such as melanoma, breast cancer, lung cancer, liver cancer, and the like. The treatment effect is broad, and the compound has certain selective killing effect against tumor cells. The invention relates to an Cu(DDC)2 injection protein nano-particle preparation used for treating tumor, and a preparation method thereof. Therefore, problems of poor water-solubility and difficulty in intravenous administration of Cu(DDC)2 are solved. According to the invention, with an ultrasonic method, a high-pressure homogenization method, and a micro-jet method, the Cu(DDC)2 injection protein nano-particles are prepared. The Cu(DDC)2 protein nano-particles are prepared from the components that (Cu(DDC)2 + organic solvent) :(protein + water) = 1:2-1:30, wherein the specification of Cu(DDC)2 is 0.01-5mg / mL, the specification of protein is 0.05-25% (w / v), and a ratio of organic solvent to water is 1:2-1:30. Proteins such as human serum albumin (HSA), bovine serum albumin (BSA), hydrophobic protein, glycoprotein, and lipoprotein or polypeptide is adopted as a carrier and a stabilizer for coating medicine particles, such that the particles have good biocompatibility and high security. Cu(DDC)2 tumor-inhibiting treatment effect is improved, and adverse reaction is reduced.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular provides a Cu(DDC) injection for treating tumors 2 Protein nanoparticle preparation and preparation method thereof. Background technique [0002] Cu(DDC) 2 (Copper Diethyldithiocarbamate), the Chinese full name is N,N-diethyldithiocarbamate copper, which is chelated by two molecules of DDC (N,N-diethyldithiocarbamate) and one molecule of copper (structure Such as formula I). DDC is the metabolite of the anti-alcoholic drug disulfiram (disulfiram, also known as disulfide tetraethylthiuram, disulfiram, structure such as formula II) in the body through the reduction of glutathione reductase system in red blood cells, and Both disulfiram and DDC are easily chelated with copper, eventually forming Cu(DDC) 2 . [0003] [0004] Formula Ⅰ [0005] [0006] Formula II [0007] The study found that Cu(DDC) 2 Positive anticancer efficacy: Nuclear transcription fact...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/19A61K31/325A61K47/42A61P35/00
Inventor 唐星吴春福杨静玉张宇林霞王艳娇何海冰胡希
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products